Chr. Michelsen Institute CMI
Daniel Sejer Pedersen is an accomplished chemical development specialist with extensive experience in the pharmaceutical industry and academia. Currently at Novo Nordisk since June 2017, Daniel holds the title of Chemical Development Specialist, where responsibilities include coordinating outsourced R&D projects for clinical phases II and III, focusing on small-molecule, peptide, and peptidomimetic chemistry. Prior to this role, Daniel served as a Senior Development Scientist at Novo Nordisk and held multiple academic positions at the University of Copenhagen, including Associate Professor and Visiting Associate Professor. Daniel's research expertise encompasses medicinal chemistry related to G protein-coupled receptors and antibiotic development. Educational qualifications include a PhD in Synthetic Organic Chemistry from the University of Cambridge and a Cand. scient. in Organic Chemistry from the University of Copenhagen.
This person is not in any teams
This person is not in any offices
Chr. Michelsen Institute CMI
Chr. Michelsen Institute (CMI) is an independent centre for research on international development and policy. CMI was founded in 1930, and is located in Bergen, Norway. CMI conducts both applied and theoretical research.